SILK ROAD MEDICAL INC (SILK)

US82710M1009 - Common Stock

17.84  +0.17 (+0.96%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to SILK. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.57. This target is 15.3% above the current price.
SILK was analyzed by 16 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SILK.
In the previous month the buy percentage consensus was at a similar level.
SILK was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 17.848.0821.4220.5729.40 - -54.71% 20.07% 15.30% 64.80%
Up and Down Grades
Date Firm Action Rating
2024-03-07 Argus Research Upgrade Hold -> Buy
2024-02-29 Stifel Maintains Buy -> Buy
2024-02-29 JP Morgan Maintains Neutral -> Neutral
2024-02-29 Piper Sandler Maintains Neutral -> Neutral
2024-01-19 Stifel Upgrade Hold -> Buy
2024-01-03 Lake Street Initiate Buy
2023-10-24 Wolfe Research Upgrade Underperform -> Peer Perform
2023-10-11 CL King Downgrade Buy -> Neutral
2023-10-11 B. Riley Securities Downgrade Buy -> Neutral
2023-10-11 Stifel Downgrade Buy -> Hold
2023-10-11 Piper Sandler Maintains Neutral -> Neutral
2023-10-11 Citigroup Downgrade Buy -> Sell
2023-09-21 Argus Research Downgrade Buy -> Hold
2023-09-06 Oppenheimer Initiate Outperform
2023-08-14 Citigroup Maintains Buy -> Buy
2023-08-02 B. Riley Securities Maintains Buy -> Buy
2023-08-02 Stifel Maintains Buy -> Buy
2023-07-12 JP Morgan Downgrade Overweight -> Neutral
2023-07-12 B of A Securities Downgrade Buy -> Underperform
2023-07-11 Citigroup Reiterate Buy -> Buy
2023-05-23 CL King Initiate Buy
2023-05-22 Argus Research Maintains Buy -> Buy
2023-05-15 Wolfe Research Downgrade Peer Perform -> Underperform
2023-05-10 Piper Sandler Maintains Neutral -> Neutral
2023-05-10 Citigroup Maintains Buy
2023-04-03 Citigroup Upgrade Neutral -> Buy
2023-03-31 B. Riley Securities Initiate Buy
2023-03-10 Citigroup Upgrade Sell -> Neutral
2023-02-07 Wolfe Research Downgrade Outperform -> Peer Perform
2022-07-18 Stifel Maintains Buy